Abstract
The aim of this study was to explore the clinical efficacy and safety of the combination of thymopeptide enteric-coated tablets and Compound Kuwei Huoxue Formula in the treatment of oral lichen planus (OLP). Using a random number table, the patients were divided into a study group and a control group after registration and enrollment. There was no significant difference in the general data comparison between the two groups (P > 0.05). After treatment, the number of cured patients in the study group was higher than that in the control group, and the number of ineffective cases was lower than that in the control group. The total cure rate in the study group was higher than that in the control group (P < 0.05). The levels of inflammatory factors interleukin-4, interleukin-6, and interferon-γ in the study group. Based on the practical clinical considerations, the treatment regimen of oral immunomodulator-thymopeptide enteric-coated tablets combined with Compound Kuwei Huoxue Formula emphasizes enhancing the immune function of the body and adopting the principle of clearing heat and detoxification in traditional Chinese medicine to achieve the goal of treating the root cause. This comprehensive treatment approach has achieved good clinical efficacy, providing new ideas and methods for the treatment of OLP that are worth promoting.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
